More articles from Drug therapies in
- You have accessDrug therapies in chronic heart failure: a focus on reduced ejection fractionHelena Bolam, Geraint Morton and Paul R KalraClin Med April 2018, DOI: https://doi.org/10.7861/clinmedicine.18-2-138
- You have accessDevelopments in therapy with monoclonal antibodies and related proteinsH Michael Shepard, Gail Lewis Phillips, Christopher D Thanos and Marc FeldmannClin Med June 2017, DOI: https://doi.org/10.7861/clinmedicine.17-3-220
- You have accessDrug therapy in anticoagulation: which drug for which patient?Carolyn M Millar and Mike A LaffanClin Med June 2017, DOI: https://doi.org/10.7861/clinmedicine.17-3-233
- You have accessDrugs for hypercholesterolaemia – from statins to pro-protein convertase subtilisin kexin 9 (PCSK9) inhibitionAnthony S Wierzbicki and Paul GrantClin Med August 2016, DOI: https://doi.org/10.7861/clinmedicine.16-4-353
- You have accessThe newer direct oral anticoagulants: a practical guideJecko ThachilClin Med April 2014, DOI: https://doi.org/10.7861/clinmedicine.14-2-165
- You have accessDrug therapies in dermatologyArif Aslam and Christopher EM GriffithsClin Med February 2014, DOI: https://doi.org/10.7861/clinmedicine.14-1-47
- You have accessRecent changes in the drug treatment of allergic asthmaDavid Gibeon and Andrew Menzies-GowClin Med October 2013, DOI: https://doi.org/10.7861/clinmedicine.13-5-477